Value Initiative: Advancing Targeted Medicine
The Society of Nuclear Medicine and Molecular Imaging recognizes the field of nuclear medicine and molecular imaging is changing. Through its Value Initiative, SNMMI is providing the strategic vision and roadmap to address these changes, demonstrate the true value of the field, and elevate nuclear medicine and molecular imaging—increasing its value to the medical community, regulators, patients, and the public. 

The Value Initiative comprises six key areas related to the organization’s work: Quality of Practice, Research and Discovery, Workforce Pipeline and Life-Long Learning, Advocacy, Outreach, and Organizational Strength and Stability. In collaboration with other medical societies and organizations, the society will lead a transformation in the field to further advance targeted medicine. 
 

Quality of Practice
C
hair: Gary L. Dillehay, MD, FACNM, FACR, FSNMMI; Northwestern Memorial Hospital
The goal of this domain is to ensure that SNMMI members are known for high-quality, value-driven performance, and delivery of patient-centered nuclear medicine practice. To achieve the high-quality desired health outcomes, SNMMI will continue to pave way for the delivery of efficient, effective and patient-centered nuclear medicine practice by its members. Learn more.

Research and Discovery
Chair: Richard L. Wahl, MD, FACNM, FACR; Washington University School of Medicine
The goal of this domain is that SNMMI advance the development and approval of nuclear medicine and molecular imaging technologies, including therapies. Realizing that innovation is essential for our field, our science should promote and encourage these advancements. Sufficient funding is an overarching issue for research, and we will strive to increase funding from a variety of sources. Learn more.

Workforce Pipeline and Life-Long Learning
Chair: Frederick D. Grant, MD; Boston Children's Hospital
The goal of this domain is to ensure that SNMMI will continue to innovate and collaborate to retain and expand the diverse pool of qualified professionals working in the field, making society the epicenter of all things related to nuclear medicine. Learn more.

Advocacy
Chair: Munir Ghesani, MD, FACNM; NYU Langone Medical Center
Central to the Advocacy domain are efforts to promote awareness among policymakers about the NM/MI field. Paramount in this area is cooperative work with other organizations and outreach with regulatory agencies and the legislature to advocate for a better approval, coverage and reimbursement process for NM/MI drugs, devices, diagnostic procedures, and therapies. Learn more.

Outreach
Chair: Vasken Dilsizian, MD; University of Maryland School of Medicine
The goal of this domain is to ensure that patients and the medical community recognize the value of nuclear medicine, molecular imaging and radionuclide therapy. We will focus on promoting nuclear medicine and positioning SNMMI as the worldwide leader in molecular imaging and radionuclide therapy. Learn more.

Organizational Strength and Stability
SNMMI has the organizational strength and sustainability to lead the field in a dynamic healthcare landscape.